Number of measured hypo- enhancing regions | Total area (in mm2) | Median area (in mm2), IQR | A Attenuation of total area (in HU) Σ ((area x attenuation) / total area) | B Attenuation of untreated parenchyma (in HU), ± SE 15 measurements in each animal | Difference in attenuation (B – A) | Corrected difference in attenuation (B–A)/B*100 | ||
---|---|---|---|---|---|---|---|---|
48 | 8454 | 94.5, 46–168 | 72 | 118 ± 2 | 46 | 39 | ||
ECT | 66 | 3178 | 31.5, 19–53 | 86 | 114 ± 2 | 28 | 25 | |
Linear | 91 | 5146 | 39, 25–75 | 82 | 123 ± 1 | 41 | 33 | |
electrodes | EP | 61 | 4538 | 51, 30–104 | 75 | 108 ± 1 | 33 | 30 |
55 | 3563 | 32, 18–92 | 122 | 165 ± 3 | 43 | 26 | ||
25 | 750* | 21, 11.5–32* | 98 | 124 ± 2 | 26 | 21 | ||
Hexagonal electrodes | ECT | 46 | 2328* | 39.5, 25–72* | 80 | 101 ± 1 | 21* | 21* |
1 week after ECT | 11 | 99** | 8, 5–11** | 74 | 99 ± 1 | 24** | 25** | |
with electrodes linear | 13 | 300** | 19, 12–27.5** | 76 | 101 ± 1 | 25** | 25** |